KALA Historical PE Ratio image   This KALA PE ratio history page last updated 3/26/2024
KALA PE History Chart
PeriodPriceGAAPTTMPE
Q3 2023
11/13/2023
5.53-3.41-14.76NA
Q2 2023
8/4/2023
14.12-4.36-17.81NA
Q1 2023
5/9/2023
15.41-6.99-22.37NA
Q4 2022
3/3/2023
16.75-6.46-52.88NA
Q3 2022
11/8/2022
5.22-8.92-80.42NA
Q2 2022
8/11/2022
16.40-17.50-93.00NA
Q1 2022
5/16/2022
37.10-20.00-104.00NA
Q4 2021
3/29/2022
75.00-34.00-108.50NA
Q3 2021
11/15/2021
105.00-21.50-102.00NA
Q2 2021
8/5/2021
159.00-28.50-105.50NA
Q1 2021
5/5/2021
297.50-24.50-98.00NA
Q4 2020
2/25/2021
386.75-27.50-100.50NA
Q3 2020
11/5/2020
363.00-25.00-104.50NA
Q2 2020
8/6/2020
458.50-21.00-113.50NA
Q1 2020
5/7/2020
592.50-27.00-127.50NA
Q4 2019
2/12/2020
313.50-31.50-138.00NA
Q3 2019
11/7/2019
185.50-34.00-144.50NA
Q2 2019
8/6/2019
219.00-35.00-142.00NA
Q1 2019
5/9/2019
347.00-37.50-137.00NA
Q4 2018
3/11/2019
431.00-38.00-122.50NA
Q3 2018
11/8/2018
382.50-31.50-107.50NA
Q2 2018
8/9/2018
642.00-30.00-104.00NA
Q1 2018
5/10/2018
848.00-23.00NANA
Q4 2017
3/26/2018
736.75-23.00NANA
Q3 2017
11/7/2017
910.00-28.00NANA
KALA Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2023
11/13/2023
5.53-3.41-13.64NA
Q2 2023
8/4/2023
14.12-4.36-17.44NA
Q1 2023
5/9/2023
15.41-6.99-27.96NA
Q4 2022
3/3/2023
16.75-6.46-25.84NA
Q3 2022
11/8/2022
5.22-8.92-35.68NA
Q2 2022
8/11/2022
16.40-17.50-70.00NA
Q1 2022
5/16/2022
37.10-20.00-80.00NA
Q4 2021
3/29/2022
75.00-34.00-136.00NA
Q3 2021
11/15/2021
105.00-21.50-86.00NA
Q2 2021
8/5/2021
159.00-28.50-114.00NA
Q1 2021
5/5/2021
297.50-24.50-98.00NA
Q4 2020
2/25/2021
386.75-27.50-110.00NA
Q3 2020
11/5/2020
363.00-25.00-100.00NA
Q2 2020
8/6/2020
458.50-21.00-84.00NA
Q1 2020
5/7/2020
592.50-27.00-108.00NA
Q4 2019
2/12/2020
313.50-31.50-126.00NA
Q3 2019
11/7/2019
185.50-34.00-136.00NA
Q2 2019
8/6/2019
219.00-35.00-140.00NA
Q1 2019
5/9/2019
347.00-37.50-150.00NA
Q4 2018
3/11/2019
431.00-38.00-152.00NA
Q3 2018
11/8/2018
382.50-31.50-126.00NA
Q2 2018
8/9/2018
642.00-30.00-120.00NA
Q1 2018
5/10/2018
848.00-23.00-92.00NA
Q4 2017
3/26/2018
736.75-23.00-92.00NA
Q3 2017
11/7/2017
910.00-28.00-112.00NA
Quotes delayed 20 minutes

Email EnvelopeFree KALA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Kala Pharmaceuticals (KALA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

KALV PE Ratio History
KDMN PE Ratio History
KDNY PE Ratio History
KEQU PE Ratio History
KIDS PE Ratio History
KIN PE Ratio History
KLDO PE Ratio History
KMPH PE Ratio History
KNTE PE Ratio History
KOD PE Ratio History
On this page we presented the KALA PE Ratio History information for Kala Pharmaceuticals' stock. The average KALA PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average KALA PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this KALA PE ratio history result, against the recent PE: when this page was posted on 3/25/2024, the most recent closing price for KALA had been 7.91, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on KALA or any other given stock, valuation analysis for KALA can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Kala Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for KALA. Thanks for visiting, and the next time you need to research KALA PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: CNL Videos, KGS Next Dividend Date, FGP Insider Buying.

 

KALA PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.